{"id":2509,"date":"2014-01-22T16:07:46","date_gmt":"2014-01-22T21:07:46","guid":{"rendered":"http:\/\/blogs.shu.edu\/ghg-development\/?p=2509"},"modified":"2014-01-22T16:43:16","modified_gmt":"2014-01-22T21:43:16","slug":"small-business-innovation-research-program-grant","status":"publish","type":"post","link":"https:\/\/blogs.shu.edu\/ghg\/2014\/01\/22\/small-business-innovation-research-program-grant\/","title":{"rendered":"Small Business Innovation Research Program–Grant"},"content":{"rendered":"

\"NIH\"<\/a><\/p>\n

Title: Small Business Innovation Research Program–Grant
\nSponsor: \u00a0National Institute of Neurological Disorders and Stroke\/NIH\/DHHS<\/p>\n

SYNOPSIS: \u00a0 \u00a0National Institute of Neurological Disorders and
\nStroke (NINDS) invites eligible United States small business concerns
\n(SBCs) to submit Small Business Innovation Research (SBIR) Phase I, Phase II, Fast-Track (NIH only), and Phase IIB Competing Renewal (NIH
\nonly) grant applications for innovative neuroscience research or neuroscience research and development (R\/R&D) that has both the potential for commercialization and public benefit. \u00a0United States SBCs that have the research capabilities and technological expertise to contribute to the R&D mission(s) of the NIH, CDC, FDA or ACF awarding components identified in this FOA are encouraged to submit SBIR grant applications in response to identified topics (see:
\nhttp:\/\/grants.nih.gov\/grants\/funding\/sbirsttr1\/2014-2_SBIR-STTR-topics
\n.pdf<\/a>). \u00a0This FOA will utilize the NIH R43\/R44 Small Business Innovation Research (SBIR) Grant – Phase I, Phase II, and Fast-Track award mechanisms.<\/p>\n

Deadline(s): \u00a0 \u00a0 \u00a004\/05\/2014
\n05\/07\/2014
\n08\/05\/2014
\n09\/07\/2014
\n12\/05\/2014
\n01\/07\/2015
\nEstablished Date: 01\/21\/2014
\nFollow-Up Date: \u00a0\u00a002\/01\/2015
\nReview Date: \u00a0 \u00a0 \u00a001\/21\/2014<\/p>\n

Contact: \u00a0 \u00a0 \u00a0 \u00a0 \u00a0Ms. Stephanie Fertig<\/p>\n

Address: \u00a0 \u00a0 \u00a0 \u00a0 \u00a06001 Executive Boulevard Suite 3309
\nBethesda, MD 20892-9531
\nU.S.A.
\nE-mail: \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0fertigs@ninds.nih.gov<\/a>
\nWeb Site:\u00a0http:\/\/grants1.nih.gov\/grants\/guide\/pa-files\/PA-14-071.html<\/a>
\nProgram URL:\u00a0http:\/\/grants.nih.gov\/grants\/funding\/sbirsttr1\/2014-2_SBIR-STTR-topics.pdf<\/a>
\nTel: \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0301-496-1779<\/a>
\nFax: \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0301-402-1501<\/a>
\nDeadline Ind: \u00a0 \u00a0 Receipt
\nDeadline Open: \u00a0 \u00a0No<\/p>\n

DEADLINE NOTE
\nApplications may be submitted to Grants.gov in response to this announcement on or after\u00a0March 5, 2014. The deadlines for receipt of standard applications under this announcement are:\u00a0April 5,\u00a0August 5 and December 5\u00a0annually. The deadlines for receipt of AIDS-related applications are: January 7,\u00a0May 7, and\u00a0September 7\u00a0annually. This program will expire on\u00a0January 8, 2015.<\/p>\n

Award Type(s): \u00a0 \u00a0Small Business Innovation Research<\/p>\n

Citizenship\/Country of Applying Institution:
\nU.S.A. Citizenship (including U.S. Territories)
\nU.S. Permanent Resident<\/p>\n

Locations Tenable: \u00a0 \u00a0U.S.A. Institution (including U.S. Territories)<\/p>\n

Appl Type(s): \u00a0 \u00a0 For-Profit
\nSmall Business<\/p>\n

Target Group(s): \u00a0NONE
\nFunding Limit: \u00a0 \u00a0$0 \u00a0 SEEBELOW
\nDuration: \u00a0 \u00a0 \u00a0 \u00a0 0
\nIndirect Costs: \u00a0 Yes
\nCost Sharing: \u00a0 \u00a0 No
\nSponsor Type: \u00a0 \u00a0 NONE<\/p>\n

Geo. Restricted: \u00a0NO RESTRICTIONS<\/p>\n

CFDA#:<\/p>\n

OBJECTIVES: \u00a0 The purpose of the SBIR Program is to stimulate
\ntechnological innovation in the private sector, strengthen the role of small business in meeting federal research or research and development
\n(R\/R&D) needs, increase the commercial application of sponsor-supported research results, foster and encourage participation by socially and economically disadvantaged small business concerns and women-owned business concerns in technological innovation. The objective of Phase I is to establish the technical\/scientific merit and feasibility of the proposed R\/R&D efforts in the development of
\nprojects that have potential for commercialization. \u00a0 Research
\ntopics are: therapeutics and diagnostics development for neurological disorders; technology and tools; clinical trials; and countermeasures against chemical threats. In addition to the specified research topics, grant applications will be considered in any area within the mission of the sponsor.<\/p>\n

ELIGIBILITY
\nOnly United States small business concerns (SBCs) are eligible to submit SBIR applications. A small business concern is one that, at the time of award, for both Phase I and Phase II awards, meets all of the following criteria: is independently owned and operated, is not dominant in the field of operation in which it is proposing, has a place of business in the United States and operates primarily within the United States or makes a significant contribution to the US economy, and is organized for profit; is (a) at least fifty-one percent owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States, or
\n(b) for SBIR only, it must be a for-profit business concern that is at least fifty-one percent owned and controlled by another for-profit business concern that is at least fifty-one percent owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States; and has, including its affiliates, an average number of employees for the preceding twelve months not exceeding 500. \u00a0Small business concerns that are more than 50% owned by multiple venture capital operating companies, hedge funds, private equity firms are now eligible to apply
\nto NIH only. \u00a0 More than one PD\/PI, or multiple PDs\/PIs, may be
\ndesignated on the application for projects that require a ?team science? approach that clearly does not fit the single-PD\/PI model. \u00a0Under the SBIR program, for both Phase I and Phase II, the primary employment of the PD\/PI must be with the small business concern at the time of award and during the conduct of the proposed project. For projects with multiple PD\/PIs, at least one must meet the primary employment requirement and will be referred to as the ?small business PD\/PI.? Primary employment means that more than one half of the PD\/PI?s time is spent in the employ of the small business concern.<\/p>\n

FUNDING
\nThis FOA will utilize the NIH R43\/R44 Small Business Innovation Research (SBIR) Grant – Phase I, Phase II, and Fast-Track award
\nmechanisms. \u00a0 According to statutory guidelines, total funding support
\n(direct costs, indirect costs, fee) normally may not exceed $150,000 for Phase I awards and $1,000,000 for Phase II awards. \u00a0With appropriate justification from the applicant, Congress will allow awards to exceed these amounts by up to 50% ($225,000 for Phase I and
\n$1,500,000 for Phase II, a hard cap). NIH has received a limited waiver from SBA, as authorized by the statute, to exceed the hard cap for specific topics. Due to the nature of the waiver, some NIH Institutes and Centers generally will not consider applications with budgets over $225,000 for Phase I and $1,500,000 for Phase II. Please refer to the appropriate Institute?s or Center?s topic section to determine whether they will consider applications above these amounts.
\nApplicants are strongly encouraged to contact NIH program officials prior to submitting any application in excess of the hard cap
\n($225,000 for Phase I and $1,500,000 for Phase II). In all cases, applicants should propose a budget that is reasonable and appropriate for completion of the research project. \u00a0According to statutory guidelines, award periods normally may not exceed 6 months for Phase I and 2 years for Phase II. Applicants are encouraged to propose a project duration period that is reasonable and appropriate for
\ncompletion of the research project. \u00a0 \u00a0 Reference: NIH Guide,
\nWeek Ending January 17, 2014. (kww)<\/p>\n

KEYWORDS: \u00a0 \u00a0 \u00a0 \u00a0 Cognitive Development\/Processes
\nRehabilitation\/Therapy
\nBrain
\nNervous System
\nNeurological Disorders
\nStroke
\nNeural Stimulation
\nNeurology
\nNeuroscience
\nChemical Effects
\nTechnology
\nBiological\/Chemical Warfare
\nNeurodegenerative Diseases\/Disorders
\nInnovation
\nBioterrorism
\nNeuroimaging
\nTranslational Research
\nGrants.gov
\nGrants.gov\/S2S<\/p>\n","protected":false},"excerpt":{"rendered":"

Title: Small Business Innovation Research Program–Grant Sponsor: \u00a0National Institute of Neurological Disorders and Stroke\/NIH\/DHHS SYNOPSIS: \u00a0 \u00a0National Institute of Neurological Disorders and Stroke (NINDS) invites eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) Phase I, Phase II, Fast-Track (NIH only), and Phase IIB Competing Renewal (NIH only) grant applications […]<\/p>\n","protected":false},"author":585,"featured_media":2512,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[244],"tags":[363,345,355,361,351,350,367,368,282,231,358,364,365,356,359,360,349,352,353,357,362,354,366],"class_list":["post-2509","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-current-openings-in-global-health","tag-biologicalchemical-warfare","tag-bioterrorism","tag-brain-nervous-system","tag-chemical-effects","tag-cognitive-development","tag-grant","tag-grants-gov","tag-grants-govs2s","tag-innovation","tag-jobs","tag-neural-stimulation","tag-neurodegenerative-diseasesdisorders","tag-neuroimaging","tag-neurological-disorders","tag-neurology","tag-neuroscience","tag-nih","tag-processes","tag-rehabilitation","tag-stroke","tag-technology","tag-therapy","tag-translational-research"],"_links":{"self":[{"href":"https:\/\/blogs.shu.edu\/ghg\/wp-json\/wp\/v2\/posts\/2509","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.shu.edu\/ghg\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.shu.edu\/ghg\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.shu.edu\/ghg\/wp-json\/wp\/v2\/users\/585"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.shu.edu\/ghg\/wp-json\/wp\/v2\/comments?post=2509"}],"version-history":[{"count":5,"href":"https:\/\/blogs.shu.edu\/ghg\/wp-json\/wp\/v2\/posts\/2509\/revisions"}],"predecessor-version":[{"id":2531,"href":"https:\/\/blogs.shu.edu\/ghg\/wp-json\/wp\/v2\/posts\/2509\/revisions\/2531"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/blogs.shu.edu\/ghg\/wp-json\/wp\/v2\/media\/2512"}],"wp:attachment":[{"href":"https:\/\/blogs.shu.edu\/ghg\/wp-json\/wp\/v2\/media?parent=2509"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.shu.edu\/ghg\/wp-json\/wp\/v2\/categories?post=2509"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.shu.edu\/ghg\/wp-json\/wp\/v2\/tags?post=2509"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}